Symmetrical flow respirator

The dual-chamber respirator with UVC radiation sources and reflective materials addresses the inefficiencies of existing UV respirators, providing effective pathogen inactivation and extended battery life through intelligent power management.

CN119095652APending Publication Date: 2024-12-06XCMR INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380021851.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-02-14
Filing Date
2023-02-14
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing UV-based respirators face challenges due to harmful radiation exposure and energy inefficiency, which hinder the development of portable devices for pathogen inactivation.

Method used

A protective respirator with dual reactor chambers, each equipped with a UVC radiation source, alternately activated based on breathing cycles, and enhanced with reflective materials and photon barriers to optimize UVC exposure and efficiency.

Benefits of technology

The respirator effectively inactivates pathogens while minimizing user exposure and extending battery life through intelligent power management and reflective materials, achieving high sterilization efficiency with reduced power consumption.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119095652A_ABST
    Figure CN119095652A_ABST
Patent Text Reader

Abstract

A protective respirator includes an inspiratory reactor chamber that treats inspiratory air and provides the inspiratory air to a user and an exhaust reactor chamber that treats exhaust exhaled by the user. The respirator uses ultraviolet C radiation to inactivate potentially harmful particles without exposing the user to radiation. In an embodiment, the respirator includes a number of features that can improve efficiency and extend battery life. For example, a protective respirator may use approximately half of power by alternating between inspiratory and expiratory reactor chambers. In addition, the respirator may adjust the intensity of UVC radiation based on the breathing intensity of the user. In addition, a reflecting material can be lined in the reactor chamber cavity, and the reflecting material can multiply the irradiance in each chamber cavity. Further, each reactor chamber cavity may include a fluid permeable photon barrier that reflects UVC photons back into the reactor chamber cavity while allowing the gas flow to pass therethrough.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims priority to U.S. Provisional Patent Application No. 63 / 310,019, filed on February 14, 2022, the entire contents of which are hereby incorporated by reference herein.

[0003] Federal Funding

[0004] none Background Art

[0005] From soldiers donning Mission Oriented Protective Posture (MOPP) suits to civilians wearing masks to protect themselves from COVID-19, many individuals want to protect themselves from inhaling pathogens and other potentially harmful particles, and from spreading those particles themselves.

[0006] Ultraviolet (UV) radiation with wavelengths between about 200 nanometers (nm) and 320 nm can cause photochemical damage to key biomolecules, such as deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Therefore, UV radiation in the 200-320 nm range (sometimes referred to as "germicidal UV") can be used to disinfect surfaces and volumes of air. UV radiation with wavelengths less than about 240 nm can also damage proteins, resulting in the inactivation of microorganisms and viruses.

[0007] However, UV radiation presents a number of technical challenges that have so far hindered the development of practical portable respirators that utilize UV ​​radiation to inactivate particles. First, radiation with wavelengths greater than 230nm can be harmful to human tissue. Additionally, due to the energy inefficiency of UV radiation sources, they generate excessive heat, which makes it challenging to develop a portable device that can provide long-term protection using batteries. Summary of the invention

[0008] To overcome these and other shortcomings of the prior art, a protective respirator is disclosed. In an embodiment, the protective respirator includes two reactor chambers, each of which is embedded with an ultraviolet C (UVC) radiation source, which can inactivate microorganisms and / or other potentially harmful particles without exposing the user to UVC radiation. The inhalation reactor chamber processes the inhaled air and provides the inhaled air to the user (e.g., through a mask), and the exhaust reactor chamber processes the exhaust gas exhaled by the user.

[0009] In various embodiments, the protective respirator includes many features that can improve efficiency and extend the battery life of the device. For example, the protective respirator can use about half the power by alternately activating and deactivating the inhalation reactor chamber and the exhalation reactor chamber according to whether the user is inhaling or exhaling. In addition, the protective respirator can adjust the intensity of the UVC radiation according to the breathing intensity of the user. In addition, the reactor chamber cavity can be lined with a reflective material, such as a microporous expanded polytetrafluoroethylene (ePTFE) material, thereby multiplying the irradiance in each chamber cavity. In addition, each reactor chamber cavity can include two fluid-permeable photon barriers that reflect UVC photons back to the reactor chamber cavity while allowing airflow in and out of the reactor chamber cavity. BRIEF DESCRIPTION OF THE DRAWINGS

[0010] Aspects of the exemplary embodiments may be better understood with reference to the accompanying drawings, in which the components are not necessarily drawn to scale, emphasis instead being placed upon illustrating the principles of the exemplary embodiments.

[0011] Figure 1 is a diagram illustrating a personal protection respirator according to an exemplary embodiment.

[0012] Figure 2 According to an exemplary embodiment Figure 1 Block diagram of a protective respirator.

[0013] Figure 3A This is the spectrum of action of the SARS-CoV-2 virus.

[0014] Figure 3B is the spectral distribution of a low-pressure mercury (LPM) lamp.

[0015] Figure 3C is the spectral distribution of UVCLED.

[0016] Figure 4A is a schematic diagram of a reactor chamber cavity according to an exemplary embodiment, wherein the UVC radiation source is an LPM lamp.

[0017] Figure 4B is a schematic diagram of a reactor chamber cavity according to another exemplary embodiment, wherein the UVC radiation source is an LPM lamp.

[0018] Figure 4C is a diagram of a reactor chamber cavity according to another exemplary embodiment, wherein the UVC radiation source is a UVC LED array.

[0019] Figure 5A is a diagram illustrating a fluid permeable photon barrier according to a first exemplary embodiment.

[0020] Figure 5B is a front view of a fluid permeable photon barrier according to a second exemplary embodiment.

[0021] Figure 5C is based on Figure 5B A side view of a fluid permeable photon barrier of an embodiment of the invention.

[0022] Figure 6 is a flow chart illustrating a UV emission process according to an exemplary embodiment.

[0023] Fig. 7A is a diagram of an example breathing pattern.

[0024] Figure 7B It is an instruction Fig. 7A An example timing diagram of a binary signal of the timing of the breathing pattern.

[0025] Figure 7C is in response to Fig. 7A breathing pattern or Figure 7B Timing diagram of the pulses that activate the inspiratory reactor chamber and the expiratory reactor chamber by the binary signal.

[0026] Fig. 8A An example laboratory experiment for measuring the intrinsic kinetics of the deactivation reaction of aerosol particles is shown.

[0027] Figure 8B Shows Fig. 8A Computer simulation of the inactivation reaction during the experiment.

[0028] Fig.9A is a block diagram of an analog ballast for an LPM lamp according to an exemplary embodiment.

[0029] Fig. 9B yes Fig.9A Circuit diagram of the simulated ballast.

[0030] Fig. 10A is a block diagram of a ballast for an LPM lamp with an integrated circuit based lamp controller according to an exemplary embodiment.

[0031] Fig. 10B yes Fig. 10A Circuit diagram of an IC based ballast.

[0032] Fig.11 is a block diagram of an IC-based ballast according to another exemplary embodiment.

[0033] Fig. 12A is a block diagram illustrating a circuit controller for adjusting UVC LED intensity according to another exemplary embodiment.

[0034] Fig. 12B It is shown Fig. 12A Circuit diagram of the circuit controller.

[0035] Fig.13 is a diagram of a network environment according to an exemplary embodiment. DETAILED DESCRIPTION

[0036] Reference is now made to the accompanying drawings of the various views showing exemplary embodiments. In the accompanying drawings and the accompanying drawings descriptions herein, certain terms are used for convenience only and should not be considered as limiting embodiments of the present invention. In addition, in the accompanying drawings and the following description, the same numbers always represent the same elements.

[0037] Figure 1 A personal protection respirator 100 is shown according to an exemplary embodiment.

[0038] exist Figure 1 In some embodiments, the protective respirator 100 is a "symmetrical flow" disinfection device that includes an inhalation reactor chamber 120a and an exhalation reactor chamber 120b, each of which is attached to a power / electronics compartment 140. In these embodiments, the protective respirator 100 is implemented as a neck collar that can be comfortably worn by the user 101, wherein the power / electronics compartment 140 is wrapped around the back of the user's 101 neck and the reactor chamber 120 rests on the user's 101 chest.

[0039] Both the inhalation reactor chamber 120a and the exhalation reactor chamber 120b embed an ultraviolet C (UVC) radiation source that can inactivate microorganisms and / or other potentially harmful particles without exposing the user 101 to UVC radiation. The inhalation reactor chamber 120a includes an intake air input port 121a for receiving untreated intake air 110a from the open atmosphere surrounding the user 101, and an intake air output port 129a, wherein the intake air input port 121a is used to receive untreated intake air 110a from the open atmosphere surrounding the user 101, and the intake air output port 129a is in flow communication with the mask 150 (e.g., through the intake tube 130) for outputting treated intake air 190a for inhalation by the user 101. Similarly, the exhalation reactor chamber 120b includes an exhaust air input port 121b and an exhaust air output port 129b, wherein the exhaust air input port 121b is used to receive untreated exhaust air 110b from the interior of the mask 150 (e.g., through the exhaust tube 170), and the exhaust air output port 129b is used to output treated exhaust air 190b to the open atmosphere. The inhalation reactor chamber 120a and the exhalation reactor chamber 120b are collectively referred to herein as reactor chambers 120. The untreated intake air 110a and the untreated exhaust air 110b are collectively referred to herein as untreated air 110. The treated intake air 190a and the treated exhaust air 190b are collectively referred to herein as treated air 190.

[0040] exist Figure 1In some embodiments, the mask 150 is a fitted mask that is configured to surround the nose and mouth of the user 101 and provide a sealed barrier between the nose and mouth of the user 101. In other embodiments, the mask 150 may be a full face shield (e.g., a helmet used by a pilot). In other embodiments, the mask 150 may be configured to provide a barrier between the nose and mouth of the user 101 that is not necessarily sealed or airtight.

[0041] Figure 2 is a block diagram of a protective respirator 100 according to an exemplary embodiment.

[0042] The protective respirator 100 includes a controller 210 and a power source 290. Figure 2 In an embodiment, the power / electronics compartment 140 also includes a communication module 220 , a geo-location module 224 , a physiological sensor 240 , and an inertial measurement unit 250 .

[0043] Controller 210 may be any suitable computing device capable of performing the functions described herein. Figure 2 In the embodiment of the present invention, the controller 210 includes a non-transitory computer readable storage medium (memory 218) and a hardware computer processor 214. In other embodiments, the controller 210 can be, for example, a finite state machine. The power supply 290 can be any hardware device (e.g., a rechargeable battery) that provides power to the protective respirator 100.

[0044] The communication module 220 may be any hardware device that enables the protective respirator 100 to communicate with other electronic devices directly and / or over a network. For example, the communication module 220 may provide functionality for the protective respirator 100 to communicate with other protective respirators 100 and / or personal electronic devices (e.g., smartphones, activity monitors, fitness trackers, etc.) using direct, short-range, wireless communications (e.g., Bluetooth). The geolocation module 224 may include any hardware device that determines or estimates the geographic location of the protective respirator 100 using, for example, satellite navigation, network identification, communication with a location beacon, etc.

[0045] Physiological sensors 240 may include any hardware device that senses data indicative of a physiological condition of user 101. Physiological sensors 240 may include: a photoplethysmogram (PPG) sensor 242 that uses a light source and a photodetector on the surface of the skin to measure volume changes in blood circulation, and / or a galvanic skin response (GSR) sensor 246 that detects changes in electrical (ionic) activity caused by changes in sweat gland activity. Data from PPG sensor 242 may be used, for example, to estimate the frequency, intensity, and amplitude of user 101's breathing.

[0046] The inertial measurement unit 250 may include any hardware device that measures and reports the motion and / or orientation of the protective respirator 200. The inertial measurement unit 250 may include an accelerometer 252, a gyroscope 254, and / or a magnetometer 256. The motion of the protective respirator 100 may affect the data captured by the physiological sensor 240. Therefore, in some embodiments, the controller 210 may determine the motion of the protective respirator 100 based on the data captured by the IMU 250 and use a digital signal processing algorithm (e.g., stored in the memory 118) to remove motion artifacts from the data captured by the physiological sensor 240.

[0047] 4, each reactor chamber 120 includes a UVC radiation source 400 and a reactor chamber cavity 420 having a reflective surface 480. Untreated air 110 passes through the reactor chamber cavity 420, wherein the untreated air 110 is exposed to UVC radiation emitted by the UVC radiation source 400, which inactivates microorganisms and / or other potentially harmful particles in the untreated air 110 to form treated air 190. The UVC radiation source 400 can be, for example, a medium-pressure or low-pressure mercury arc lamp, a light-emitting diode (LED), a laser diode, an excimer lamp (e.g., an optically filtered krypton-chloride (KrCl*) excimer lamp as described in U.S. Patent Application No. 17 / 644,041), an excimer laser, a micro-plasma lamp, and the like.

[0048] As described in detail below with reference to FIG. 5 , each reactor chamber cavity 420 may include two fluid permeable photon barriers 500 that reflect UVC photons back into the reactor chamber cavity 420 while allowing nearly unimpeded airflow into and out of the reactor chamber cavity 420 .

[0049] To help regulate the temperature of the UVC radiation source, each reactor chamber 120 may include a heat sink 230 that transfers excess heat 232 generated by the UVC radiation source 400 to a fluid medium (e.g., a liquid coolant or air). In other embodiments, the excess heat 232 may be transferred to, for example, a thermally conductive paste, a copper conformal coating with a polymer-coated electrical insulation layer, a vapor chamber, etc. In some embodiments, the reactor chamber 120 may include a cooling fan 234 to dissipate the excess heat 232 out of the heat exhaust port 232 and away from the reactor chamber 120. (In some embodiments, the exhalation reactor chamber 120b may exhaust the excess heat 232 through the exhaust output port 129b.)

[0050] like Figure 2As shown, the inhalation reactor chamber 120a outputs treated intake air 190a through a one-way check valve 260a, while the exhalation reactor chamber 120b receives untreated exhaust air 110b through a one-way check valve 260b. Each check valve 260a and 260b is configured to allow airflow to flow in one direction and prevent reverse flow. For example, each check valve 260a and 260b can be configured to be closed unless opened by pressure in the direction of flow. For example, the check valve 260a of the inhalation reactor chamber 120a is opened by the pressure generated by the inhalation of the user 101, and is closed when the inhalation pressure is no longer maintained. Similarly, the check valve 260b of the exhalation reactor chamber 120b is opened by the pressure generated by the exhalation of the user 101, and is closed when the exhalation pressure is no longer maintained. Brief return Figure 1 The one-way check valves 260a and 260b ensure unidirectional airflow, wherein the treated intake air 190a flows into the mask 150 after being processed by the inhalation reactor chamber 120a, and the untreated exhaust air 110b flows out of the mask 150 and enters the open atmosphere after being processed by the exhalation reactor chamber 120b.

[0051] The inhalation reactor chamber 120a includes an inhalation sensor 270a, and the exhalation reactor chamber 120b includes an exhalation sensor 270b. Figure 6 Flowchart and Fig. 7A and Figure 7B As described in detail in the timing diagram of FIG. 1 , each of the inhalation sensor 270a and the exhalation sensor 270b captures and outputs information indicating the timing of the breathing (i.e., inhalation or exhalation) of the user 101. In these embodiments, for example, each check valve 260a and 260b may include an integrated switch that opens or closes when the check valve 260a or 260b is open. In other embodiments, the inhalation sensor 270a or the exhalation sensor 270b may capture and output information indicating the intensity of the inhalation or exhalation of the user 101. For example, the inhalation sensor 270a or the exhalation sensor 270b may be a differential pressure sensor that measures the flow rate across the associated check valve 260a or 260b.

[0052] The protective respirator 100 is configured to inactivate at least one specific potentially harmful particle in the untreated air 110 by emitting UVC radiation from a UVC radiation source 400. The specific particle can be, for example, a microorganism (e.g., bacteria, spores, viruses, protozoa, and / or fungi) or other aerosol biological threats (e.g., chemical agents). Since each particle has its own inherent action spectrum (i.e., absorption of ultraviolet radiation of different wavelengths) and each potential UVC radiation source has its own characteristic emission spectrum, the protective respirator 100 can include a UVC radiation source 400 that is configured to emit UVC radiation of a wavelength that is absorbed by a specific particle.

[0053] Figure 3A is an action spectrum showing the absorbance of ribonucleic acid (RNA) of the SARS-CoV-2 virus at wavelengths along the spectrum. Figure 3B is a spectral distribution showing the relative emission intensity of a low pressure mercury (LPM) lamp at wavelengths along the spectrum. Figure 3C is a spectral distribution showing the relative emission intensity of a UVC LED at wavelengths along the spectrum.

[0054] like Figure 3A As shown, the action spectrum of the SARS-CoV-2 virus includes a peak at 260 nm (corresponding to the peak absorbance of genomic nucleic acids) and a second peak or shoulder at wavelengths below 240 nm (absorbed by both nucleic acids and proteins). Figure 3B As shown in Figure 1, the LPM lamp emits almost monochromatic radiation at a characteristic wavelength of 253.7 nm. Figure 3C As shown, UVC LEDs emit radiation between 265nm and 280nm, with the highest virucidal effect at 280nm. Therefore, in an embodiment configured to inactivate the SARS-CoV-2 virus, the UVC radiation source 400 can be an LPM lamp or a UVC LED.

[0055] In some embodiments, the UVC radiation source 400 can be a polychromatic radiation source (e.g., an LED array or other UVC radiation source 400 having a range of different wavelengths). In these embodiments, the UVC radiation source 400 can emit a broad spectrum of UV radiation (to inactivate a variety of potential particles), or the controller 210 can output a control signal to selectively emit UV radiation of a specific wavelength (to selectively inactivate specific particles). In other embodiments, the protective respirator 100 can be configured to utilize any of a plurality of modular UVC radiation sources 400 having different wavelengths, such that the protective respirator 100 can be configured and reconfigured to inactivate specific particles using each modular UVC radiation source 400.

[0056] Figure 4A is a schematic diagram of a reactor chamber cavity 420 according to an exemplary embodiment, wherein the UVC radiation source 400 is an LPM lamp 400a. Figure 4B is a schematic diagram of a reactor chamber cavity 420 according to another exemplary embodiment, wherein the UVC radiation source 400 is another LPM lamp 400b. Figure 4C is a schematic diagram of a reactor chamber cavity 420 according to another exemplary embodiment, wherein the UVC radiation source 400 is an array of UVC LEDs 400c.

[0057] like Figure 4A and Figure 4BAs shown, LPM lamp 400a or 400b may be located within reactor chamber cavity 420 to emit UVC radiation within reactor chamber cavity 420. Figure 4C As shown, UVC LED 400c can be mounted outside of reactor chamber cavity 420 and emit UVC radiation through a hole in reactor chamber cavity 420. Figure 4C As shown, the reactor chamber cavity 420 may include baffles 410 to increase the time required for particles to traverse the length of the reactor chamber cavity 420 and minimize the activity of potentially harmful particles.

[0058] LPM lamps 400a and 400b have several advantages, most notably lower heat output and electrical efficiency several times higher than UV LED 400c. On the other hand, LPM lamps 400a and 400b require high voltage and do not have instant start.

[0059] UV LEDs 400c have poor electrical efficiency (3-5%), require thermal management to mitigate the larger heat distribution, and cost more than LPM lamps 400a or 400b. However, UV LEDs 400c are rapidly becoming more efficient, have higher power densities (allowing arrays to be built so that systems can be easily expanded), and are more durable than LPM lamps 400a or 400b (i.e., they are sealed and resistant to shock and vibration). Finally, because UV LEDs 400c are directional UV radiation sources 400, it is easier to control the location where the UV radiation is emitted.

[0060] As described in detail below, the protective respirator 100 is configured to extend the battery life of the power source 290 while maintaining a threshold probability of inactivating at least one particle by maximizing sterilization and energy efficiency. To this end, the inner surface of the reactor chamber cavity 420 can be composed of or coated with a UV reflective material 480. The reflective material 480 can be, for example, stainless steel, galvanized pipes, special UV reflective aluminum, microporous expanded polytetrafluoroethylene (ePTFE) material, etc. Special UV reflective aluminum can reflect up to 76% of UVC radiation. At the same time, the microporous ePTFE material can reflect up to 98% of UVC radiation.

[0061] Sumpner's Principle of Irradiance in a closed system states that the total irradiance E within the reactor chamber cavity 420 is equal to the sum of the direct irradiance ED from the UVC radiation source 400 and the indirect irradiance ER reflected from the reflective material 480. The indirect irradiance ER is calculated by comparing the indirect irradiance ER with the ideal direct irradiance ED without losses and is defined as:

[0062] EREDx(R / (1-R))

[0063] where R is the reflectivity of the reflective surface 480. Due to this relationship, a slight increase in the reflectivity R of the reflective surface 480 will translate into an exponential increase in the average total irradiance E.

[0064] In a preferred embodiment, the reflective material 480 is a microporous sintered expanded PTFE (ePTFE) which has a nearly perfect diffuse (Lambertian) reflectivity and is resilient to UV degradation. Experiments using a 254nm UVC source 400 and the ePTFE reflective material 480 have recorded up to 20 times amplification in the UV spectrum. Due to the exponential relationship between reflectivity and irradiance, increasing the reflectivity from 90% to 96% produces a greater gain than increasing the reflectivity R from 70% to 90%. Thus, an increase in reflectivity between stainless steel surfaces has been shown to increase irradiance by about 10 times compared to a reflective ePTFE material.

[0065] In some embodiments, the reflective surface 480 may be electrostatically treated to collect particles to extend the UVC dose and inactivate certain threats. For example, a nano-coating of agents may enhance the effectiveness of the reactor 12 with reactive photocatalysis.

[0066] As described above, each reactor chamber 120 includes an input port 121 for receiving untreated air 110 and an output port 129 for outputting treated air 190. At both inlet and outlet locations, there is a potential loss of photons and a reduction in optical efficiency, which may result in a reduction in flux within the reactor chamber cavity 420. Therefore, each reactor chamber cavity 420 may include two internal fluid permeable photon barriers 500 (composed of or coated with reflective material 480) that reflect UV radiation back into the reactor chamber cavity 420 while allowing airflow to pass through the fluid permeable photon barriers 500 with little hindrance.

[0067] Figure 5A is a diagram illustrating a fluid permeable photon barrier 500 according to a first exemplary embodiment.

[0068] like Figure 5A As shown, each fluid permeable photon barrier 500 may include a series of louvered slats (or other baffles) that reflect UV photons back toward the reactor chamber cavity 420 while allowing the intake air 110 or exhaust air 190 to pass through the fluid permeable photon barrier 500 .

[0069] Figure 5B is a front view of a fluid permeable photon barrier 500 according to a second exemplary embodiment. Figure 5C is based on Figure 5BA side view of a fluid permeable photon barrier 500 of an embodiment of the invention.

[0070] like Figure 5B and Figure 5C As shown, each fluid permeable photon barrier 500 may include a series of frustoconical holes 520 that cause UVC radiation to propagate according to Knudsen molecular flow. The holes 520 may be designed to minimize UVC radiation propagation losses while also minimizing gas dynamic losses, which may reduce or eliminate the efficiency gains of using reflective material 480. For example, to ensure a low pressure drop across the fluid permeable photon barrier, the total hole size may be greater than 40% of the inlet hole cross-sectional area.

[0071] In some embodiments, the protective respirator 100 is configured to provide a threshold probability (e.g., 90%, 99%, 99.9%, etc.) of inactivating specific particles (e.g., SARS-CoV-2, etc.) that pass through the reactor chamber cavity 420. The probability p of inactivating specific particles (or the proportion of these particles that are inactivated) during irradiation depends on the flux D of the UVC radiation and the magnetic susceptibility constant k of the specific particles:

[0072] p=1-eD*k

[0073] At the same time, the flux D of the UVC radiation depends on the intensity I of the UVC radiation along the path of the particle and the time t that the particle is exposed to the UVC radiation:

[0074] DI(t)·dt

[0075] To provide a threshold probability p of inactivating particles, each reactor chamber cavity 420 can be configured to continuously emit UVC radiation at a constant intensity I. However, in a preferred embodiment, the protective respirator 100 includes several features to extend the battery life of the power source 290. Most notably, the protective respirator 100 can use approximately half the power by alternately activating and deactivating the inhalation reactor chamber cavity 420a and the exhalation reactor chamber cavity 420b depending on whether the user 101 is inhaling or exhaling.

[0076] Figure 6 is a flow chart illustrating a UV emission process 600 according to an exemplary embodiment.

[0077] like Figure 6 As shown, the controller 210 identifies whether the user 101 is inhaling or exhaling in step 610. In response to determining that the user 101 is inhaling, the controller 210 enables the inhalation reactor chamber 120a in step 624 and disables the exhalation reactor chamber 120b in step 626. Alternatively, in response to determining that the user 101 is exhaling, the controller 210 disables the inhalation reactor chamber 120a in step 634 and enables the exhalation reactor chamber 120b in step 636.

[0078] Furthermore, the speed at which particles traverse the reactor chamber cavity 420—and, by extension, the time t that the particles are exposed to UVC radiation—depends on the breathing intensity of the user 101. Thus, in some embodiments, the controller 210 may estimate the user's inhalation intensity 640 in step 624 and, in step 650, adjust the intensity I of UV radiation output by the inhalation reactor chamber 120a or the exhalation reactor chamber 120b (e.g., to provide a threshold probability p of inactivating the particles within the time t that the particles are exposed to UVC radiation).

[0079] In the above-described embodiments, where the inhalation sensor 270a and the exhalation sensor 270b measure the flow rate of each check valve 260a and 260b, the controller 210 can determine the user's breathing intensity based on the flow rate measured by each of the inhalation sensor 270a and the exhalation sensor 270b. However, in other embodiments, the inhalation sensor 270a and the exhalation sensor 270b can simply output a signal indicating whether the check valve 260a or 260b is open or closed. Therefore, in these embodiments, the controller 210 can estimate the user's breathing intensity based on the user's activity level (e.g., based on data from one or more physiological sensors 240, geographic location module 224, and / or inertial measurement unit 250), the altitude of the user 101 (e.g., determined by the geographic location module 224), or information indicating the user's physiological condition (e.g., gender, weight, height, smoking status, lung health, etc.) stored in, for example, the memory 218.

[0080] Process 600 is recursive to repeatedly activate and deactivate each reactor chamber 120. Controller 210 may also monitor the temperature of reactor chamber 120 in step 602 (and reduce the intensity I of the UVC radiation if the temperature of reactor chamber 120 exceeds a predetermined threshold) and monitor power supply 290 in step 604 (and reduce the intensity I of the UVC radiation if the remaining power is below a predetermined threshold).

[0081] Fig. 7A is a graph of an example breathing pattern 720 . Figure 7B is an example timing diagram of a binary signal 740 indicating the timing of a breathing pattern 740 .

[0082] In the above embodiment, the inhalation sensor 270a and the exhalation sensor 270b measure the flow rate of each check valve 260a and 260b, and the controller 210 can identify the breathing pattern 720 - including the breathing time and the estimated breathing intensity - based on the flow rate measured by each of the inhalation sensor 270a and the exhalation sensor 270b. In other embodiments, each check valve 260a and 260b, the inhalation sensor 270a and the exhalation sensor 270b output a signal when the relevant check valve 260a or 260b is opened or closed. In these embodiments, the signals output by the inhalation sensor 270a and the exhalation sensor 270b can form a binary signal 740. In other embodiments, the protective respirator can include a microphone, and the controller can use a signal processing algorithm (e.g., received and stored in the memory 218) to identify inhalation and exhalation based on the user's breathing sounds captured by the microphone. In other embodiments, controller 210 may identify each inhalation and exhalation by predicting these inhalations and exhalations based on the user's activity level (e.g., based on data from one or more physiological sensors 240, geolocation module 224, and / or inertial measurement unit 250), the altitude of user 101 (e.g., determined by geolocation module 224), or information indicating the user's physiological condition (e.g., gender, weight, height, smoking status, lung health, etc.) stored, for example, in memory 218. For example, controller 210 may store multiple profiles (e.g., stored in memory 218) associated with multiple factors (e.g., the user's activity level, altitude, the user's physiological condition) and associated with a signal similar to binary signal 740 (e.g., a sine wave, a square wave, a sawtooth wave). In these cases, controller 210 may predict the user's inhalation and exhalation by selecting a stored profile and identifying the signal associated with the stored profile.

[0083] Figure 7C is in response to an exemplary embodiment Fig. 7A Breathing mode 720 or Figure 7B 1. A timing diagram of a binary signal 740, a pulse 760 for activating the inhalation reactor chamber 120a and a pulse 780 for activating the exhalation reactor chamber 120b.

[0084] To determine the UVC radiation intensity I required to achieve a predetermined probability p to deactivate particles, the controller 210 can use a mathematical model developed based on laboratory experiments and computational fluid dynamics (e.g., stored in the memory 218). The mathematical model can be any description of the system through a set of variables (e.g., real numbers, Boolean values, etc.) and a set of relationships between these variables. The mathematical model can be, for example, a formula or a lookup table (stored, for example, in the memory 218) for determining the UVC radiation intensity I required to achieve a predetermined probability p of inactivating particles taking into account the variables described herein (e.g., the user's breathing intensity, etc.).

[0085] Fig. 8A An example laboratory experiment 800 is shown for measuring the inherent kinetics of the inactivation reaction of aerosol particles.

[0086] In the example laboratory experiment 800, aerosol particles are introduced into a quartz channel 850 using a nebulizer 810. The quartz channel 850 includes a UVC radiation source 400 (e.g., an LPM lamp 400a or 400b or a UVC LED 400c). The aerosol particles are exposed to UVC radiation while passing through the quartz channel 850. Samples are collected at the output of the quartz channel 850 using a bioaerosol sampler 890. These samples are then analyzed to determine the inactivation reaction of the aerosol particles exposed to the UVC radiation.

[0087] To determine the inactivation response of known viruses, laboratory experiments are performed using biological surrogates of these pathogens. For example, experiments are performed using bacteriophages that have the ability to infect bacteria but not the ability to affect human tissue. To determine the inactivation response of coronaviruses, for example, bacteriophages are selected that have a similar response to UV radiation as these coronaviruses. For example, T1 and T1UV phages, Φ6 phages, Qβ phages, and murine hepatitis virus (MHV) all have similar log-linear (first order) behavior and are slightly conservative for coronaviruses.

[0088] After measuring the inherent dynamics of the inactivation reactions of known pathogens using these laboratory experiments, the inactivation reactions of these known pathogens were then simulated through computer models using computational fluid dynamics.

[0089] Figure 8B A computer simulation of the inactivation reaction during experiment 800 is shown. Heat map 840 is a plot of the velocity vector field through quartz channel 850. Image 860 is a contour plot of the flux rate of one of the UVC radiation sources 400. Combining this velocity field and the flux rate of the UVC radiation source 400 with the inactivation kinetics of a specific pathogen enables the system to develop a mathematical model that predicts the inactivation reaction of a specific pathogen as it passes through channel 850, as shown in image 880.

[0090] In embodiments where the UVC radiation source 400 is an LPM lamp 400a or 400b, each reactor chamber 120 may include a ballast to preheat and ignite the LPM lamp 400a or 400b and to activate or deactivate the LPM lamp 400a or 400b (or to adjust the intensity I of the UVC radiation by dimming the LPM lamp 400a or 400b).

[0091] Fig.9A is a block diagram of an analog ballast 900 for an LPM lamp 400a or 400b according to an exemplary embodiment. Fig. 9B yes Fig.9A A circuit diagram of the simulated ballast 900.

[0092] like Fig.9A and Fig. 9B As shown, the ballast 900 includes an LC resonant tank 960, a self-excited oscillation control circuit 940, and a dimming circuit 980. Fig.9A and Fig. 9B As shown, the ballast may include a power boost circuit 910 to boost the power supplied by the power supply 290. The LC resonant tank 960 causes the LPM lamp 400a or 400b to oscillate at the resonant frequency of the LPM lamp 400a or 400b. The LC resonant tank 960 also provides feedback on the transformer T1 to turn on and off the transistors Q1 and Q2 of the self-excited oscillation control circuit 940, thereby driving the LC resonant tank 960. The dimming circuit 980 includes a variable resistor Rd and a capacitor Cd. The controller 210 controls the intensity of the UVC radiation by adjusting the resistance of the variable resistor Rd. The addition of the capacitor and resistor network reduces the slope of the magnetizing current and the current through the RC network, resulting in a negative correlation with the operating frequency. Therefore, the smaller the resistor Rd, the higher the lamp power. When the lamp frequency moves above resonance, the Q factor decreases and the current decreases, resulting in a dimming effect.

[0093] Due to the non-linear behavior of CCFL and MPL lamps 400a and 400b, a resonant LC circuit is ideal and provides an inexpensive, reliable, and efficient control structure.

[0094] Fig. 10A is a block diagram of a ballast 1000 for an LPM lamp 400a or 400b with an integrated circuit based lamp controller 1020 according to an exemplary embodiment. Fig. 10B yes Fig. 10A A circuit diagram of an IC based ballast 1000.

[0095] The push-pull drive scheme generates a low voltage DC signal into a high voltage AC signal required to drive a low pressure mercury lamp. By adjusting the on-time of the MOSFET, the current is regulated, and additional burst dimming is achieved by using a digital pulse width modulation signal. The IC-based ballast 1000 does not rely on resonant frequency; instead, the lamp controller 1020 sets the lamp frequency and current feedback for frequency regulation.

[0096] Fig.111 is a block diagram of a ballast 1100 for an LPM lamp 400a or 400b according to another exemplary embodiment. A current-fed push-pull topology is used to power an LPM mercury lamp 400a or 400b. The circuit consists of a buck stage, a resonant push-pull stage, and an output stage. The buck power stage includes a metal oxide field effect transistor Sbuck, a flyback diode Dbuck, and an inductor Lbuck. The integrated ballast controller 1020 matches the buck frequency to the push-pull stage. The LC resonant tank 960 generates a sinusoidal voltage and causes the output of the buck stage to become a full-wave rectified voltage referenced to Vbat. Transistors Q1 and Q2 are alternately driven by the resonant frequency and the floating AC voltage, and there is an auxiliary winding on the transformer Tl. Transistors Q1 and Q2 operate at a 50% duty cycle and supply the current of the buck inductor to each side of the LC resonant tank 960 at the resonant frequency. The LPM lamp 400a or 400b is driven with a sinusoidal current and voltage through the LC resonant tank 960 and driven by a DC current source lbuck. The transformer T1 amplifies the sinusoidal tank voltage to generate a sinusoidal secondary voltage that is distributed between the LPM lamp 400a or 400b and the ballast capacitor.

[0097] IC-based ballasts 1000 and 1100 are more complex and cost more than analog ballasts 900, but provide improved dimming control by adjusting the phase angle or directly changing the lamp voltage using an integrated buck converter. IC-based lamp controllers 1020 also have additional internal management and safety features such as overvoltage, zero voltage detection, open lamp detection, soft start, etc. Some lamp controllers 1020 even provide feedback to controller 210 to control the chip or monitor for faults.

[0098] In an embodiment where the UVC radiation source 400 is a UVC LED 400c, the intensity I of the UVC radiation can be adjusted by adjusting the current through the UVC LED 400c. However, in a preferred embodiment, the intensity I of the UVC radiation can be adjusted by pulse-driving the UVC LED 400c and modulating the pulse width to adjust the ratio of the time that the UVC LED 400c emits UVC radiation relative to the time that the UVC LED 400c does not emit UVC radiation.

[0099] Fig. 12A is a block diagram illustrating that a circuit controller 1250 adjusts the intensity of a UVC LED 400c according to another exemplary embodiment. Fig. 12B It is shown Fig. 12A A circuit diagram of a circuit controller 1250.

[0100] The LT3762 has a synchronous DC / DC boost converter and a constant current source output chip. It drives a high power LED 400c from a battery source 290 with excellent efficiency and low losses, making it suitable for protective respirators without the need for additional components and dedicated power supplies. The controller 210 provides two signals to the LED driver 1250, an enable signal for turning on the LED 400c and a PWM generated dimming signal, which is provided to the chip, which proportionally adjusts the LED forward current.

[0101] Fig.13 is a diagram of a network environment 1300 according to an exemplary embodiment.

[0102] like Fig.13 As shown, the protective respirator 100 can communicate with the server 1320 via one or more wide area networks 1050 such as the Internet (e.g., using the communication module 220). In some embodiments, each protective respirator 100 is configured to communicate with other protective respirators 100 (e.g., via Bluetooth, a local area network, a cellular network, etc.) to form a mesh network. Additionally or alternatively, the protective respirator 100 can be paired with a personal electronic device 1340 (e.g., a smartphone) using a direct wireless communication protocol (e.g., Bluetooth). In these embodiments, the protective respirator 100 can communicate with the server 1320 via the personal electronic device 1340 and / or the mesh network of personal respirators 100. In some of these embodiments, the personal respirator 100 and / or the personal electronic device 1340 can also be paired with an activity tracker 1360 (e.g., a fitness tracker, a wristband, a smart watch, etc.). At the same time, in these embodiments, the above reference Figure 2 The depicted geo-location module 224 , physiological sensor 240 , and / or IMU 250 may be incorporated into a personal electronic device 1340 and / or an activity tracker 1360 .

[0103] By communicating with the server 1320, the protective respirator 100 is able to receive a mathematical model (developed using computational fluid dynamics and the inherent inactivation dynamics determined in the laboratory experiments as described above) that the controller 210 uses to determine the required UV-C radiation intensity I to deliver the required flux D to achieve a predetermined probability p of inactivating a particular particle (e.g., SARS-CoV-2) as it passes through each reactor chamber cavity 420. The protective respirator 100 can also upload performance data, usage data, and other telemetry data to the server 1320 for further aggregation and analysis.

[0104] In some embodiments, multiple protective respirators 100 in close proximity (e.g., soldiers or pilots on the same vehicle or transport aircraft) can work together to achieve a predetermined probability p of inactivating a given particle in the surrounding atmosphere. In these embodiments, the protective respirators 100 can determine the number of protective respirators 100 in close proximity (e.g., using short-range direct wireless messaging, infrared or other close-range detection, etc.) and determine the required UVC radiation intensity I (as shown in the above mathematical model) so that the protective respirators 100 collectively achieve the predetermined probability p of inactivating a given particle.

[0105] In other embodiments, the protective respirator 100 may determine the UVC radiation intensity I required to achieve a predetermined probability p of inactivating a given particle based on the number of people in close proximity (e.g., determined using infrared or other proximity detection, etc.).

[0106] In some embodiments, the UVC radiation intensity I required for the protective respirator 100 to achieve a predetermined probability p of inactivating a specified particle can be based on an estimated concentration of the specified particle in the geographic location of the protective respirator 100. For example, the controller 210 can receive an indication that the specified geographic area may include a relatively high concentration of the specified particle, determine (e.g., using the geolocation module 224) that the protective respirator is located within the specified geographic area, and adjust the UVC radiation intensity I as described above to achieve a predetermined probability p of inactivating the specified particle in the untreated intake air 110a having a relatively high concentration of the specified particle.

[0107] In the above-described embodiments, the protective respirator 100 is a "symmetrical flow" disinfection device that includes an inhalation reactor chamber 120a and an exhalation reactor chamber 120b. In some embodiments, the protective respirator 100 may have a low power mode in which only the inhalation reactor chamber 120a is activated (e.g., when the power source 290 is low and / or the user 101 is alone). In still other embodiments, the protective respirator 100 may include only the inhalation reactor chamber 120a for providing the user with treated intake air 190a.

[0108] Although preferred embodiments have been described above, those skilled in the art, having read this disclosure, will readily appreciate that other embodiments may be implemented within the scope of the invention. Therefore, the present invention should be construed as being limited only by any appended claims.

Claims

1. Symmetrical flow respirator, including: A getter reactor chamber, the getter reactor chamber comprising: a first reactor chamber cavity receiving untreated inlet gas from the atmosphere surrounding the user; and a first ultraviolet radiation source that irradiates the untreated intake air to form treated intake air for inhalation by the user; and An exhalation reactor chamber, the exhalation reactor chamber comprising: a second reactor chamber cavity that receives unprocessed exhaust gas exhaled by the user; and A second ultraviolet radiation source irradiates the untreated exhaust gas to form treated exhaust gas for dissipation into the atmosphere surrounding the user.

2. The respirator of claim 1 , further comprising a controller configured to: identifying an inhalation by the user; outputting a control signal to cause the inhalation reactor chamber to irradiate the untreated intake air in response to the user's inhalation; identifying the user's exhalation; and A control signal is outputted to cause the exhalation reactor chamber to irradiate the untreated exhaust gas in response to the exhalation of the user.

3. The respirator of claim 1 , wherein the controller is further configured to: In response to an inhalation by the user, outputting a control signal to deactivate the exhalation reactor chamber; and In response to the user's exhalation, a control signal is output to deactivate the inhalation reactor chamber.

4. The respirator of claim 2, wherein the controller is further configured to: identifying the intensity of the user's inhalation; and Based on the intensity of the user's inhalation, a control signal is output to adjust the intensity of the ultraviolet radiation irradiating the untreated intake air.

5. The respirator of claim 4, wherein the controller uses a mathematical model to select the intensity of the ultraviolet radiation based on the intensity of the user's inhalation.

6. The respirator of claim 5, wherein the controller: identifying an inhalation of the user in response to a signal output by an inhalation sensor, the inhalation sensor detecting opening of a check valve of the inhalation reactor chamber; and The user's exhalation is identified in response to a signal output by an exhalation sensor, which detects the opening of a check valve of the exhalation reactor chamber.

7. The respirator of claim 6, wherein: The inhalation sensor is an inhalation flow rate sensor that detects the intensity of the user's inhalation by detecting the flow rate of the processed intake air.

8. The respirator of claim 2, wherein the controller is configured to identify the user's inhalation and the user's exhalation by predicting the user's inhalation and the user's exhalation based on the user's activity level, the altitude of the respirator, or information indicative of the user's physiological condition.

9. The respirator of claim 1, wherein interior surfaces of the first reactor chamber cavity and the second reactor chamber cavity include a reflective material for reflecting ultraviolet radiation.

10. The respirator of claim 1 , wherein each of the first reactor chamber cavity and the second reactor chamber cavity comprises two fluid permeable photon barriers that reflect ultraviolet radiation while allowing airflow through the fluid permeable photon barriers.

11. A method of inactivating at least one particle via a symmetrical flow respirator, the method comprising: receiving unprocessed inlet gas from the atmosphere surrounding the user through the first reactor chamber cavity; irradiating the untreated intake air with a first ultraviolet radiation source to form treated intake air; outputting the processed intake air for inhalation by the user; receiving unprocessed exhaust gas exhaled by the user through a second reactor chamber cavity; and The untreated exhaust gas is irradiated by a second ultraviolet radiation source.

12. The method according to claim 11, further comprising: identifying an inhalation of the user; as well as identifying the user's exhalation, Wherein, in response to the user's inhalation, the unprocessed intake air is irradiated, and in response to the user's exhalation, the unprocessed exhaust air is irradiated.

13. The method according to claim 11, further comprising: in response to an inhalation by the user, deactivating the exhalation reactor chamber; as well as In response to exhalation by the user, the inhalation reactor chamber is deactivated.

14. The method according to claim 12, further comprising: identifying the intensity of the user's inhalation; as well as The intensity of the ultraviolet radiation irradiating the untreated intake air is adjusted based on the intensity of the user's inhalation.

15. The method of claim 14, wherein the intensity of the ultraviolet radiation is selected based on the intensity of the user's inhalation using a mathematical model.

16. The method according to claim 15, further comprising: detecting opening of a check valve of the aspiration reactor chamber; as well as detecting opening of a check valve of the exhalation reactor chamber, Therein, the inhalation of the user is identified based on the opening of the check valve of the inhalation reactor chamber, and the exhalation of the user is identified based on the opening of the check valve of the exhalation reactor chamber.

17. The method of claim 16, wherein the strength of the user's inhalation is identified by detecting a flow rate through the check valve of the inhalation reactor chamber.

18. The method of claim 12, wherein identifying the user's inhalation and the user's exhalation comprises: The user's inhalation and the user's exhalation are predicted based on the user's activity level, the respirator's altitude, or information indicative of the user's physiological condition.

19. The method of claim 11, wherein interior surfaces of the first reactor chamber cavity and the second reactor chamber cavity include a reflective material for reflecting ultraviolet radiation.

20. The method of claim 11, wherein each of the first reactor chamber cavity and the second reactor chamber cavity comprises two fluid permeable photon barriers that reflect ultraviolet radiation while allowing airflow through the fluid permeable photon barriers.